Ditchcarbon
  • Customers
  1. Organizations
  2. Antares Pharma, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Antares Pharma, Inc.

Company website

Antares Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 1978, the company has established itself as a pioneer in the development of innovative drug delivery systems, particularly in the areas of injectable pharmaceuticals. With a focus on enhancing patient compliance and improving therapeutic outcomes, Antares Pharma offers a range of unique products, including its proprietary auto-injector technology and transdermal delivery systems. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and the successful launch of several key products. Antares Pharma's commitment to innovation and quality has positioned it as a trusted name in the market, making substantial contributions to the fields of endocrinology, pain management, and other therapeutic areas.

DitchCarbon Score

How does Antares Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Antares Pharma, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Antares Pharma, Inc.'s reported carbon emissions

Antares Pharma, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary of Halozyme Therapeutics, Inc., which may influence its climate commitments and emissions reporting. As of now, Antares Pharma has not established any documented reduction targets or initiatives related to carbon emissions. This lack of specific targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction. However, without specific data or commitments from Antares Pharma, it is challenging to assess their current environmental impact or future plans. Overall, while Antares Pharma is part of a broader industry trend towards climate responsibility, further information is needed to evaluate their specific emissions profile and climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Antares Pharma, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Antares Pharma, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Antares Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Owen Mumford

GB
•
Health and social work services (85)
Updated 4 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

MDP

GB
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Perrigo

IE
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Mylan, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy